Risk Factors Predicting Outcomes in Advanced Upper Gastrointestinal Cancers Treated With Immune Checkpoint Inhibitors
Baseline risk factors and monitoring blood counts can help predict outcomes in ICI-treated UGI tumors. We need larger studies to confirm this.
Authors
- Anne M. Noonan (ORCID: https://orcid.org/0000-0001-8083-8492)
- Pannaga Malalur (ORCID: https://orcid.org/0000-0002-9222-4321)
- Katherine A. Benson (ORCID: https://orcid.org/0000-0003-3529-315X)
- Arjun Mittra (ORCID: https://orcid.org/0000-0001-9572-3495)
- Fode Tounkara (ORCID: https://orcid.org/0009-0004-4756-5903)
- Ashish Manne (ORCID: https://orcid.org/0000-0003-2356-5162)
- Kenneth L. Pitter (ORCID: https://orcid.org/0000-0002-9450-313X)
- Ning Jin (ORCID: https://orcid.org/0000-0002-6689-4671)
- Eric Miller (ORCID: https://orcid.org/0000-0002-2028-8086)
- Shafia Rahman (ORCID: https://orcid.org/0000-0003-4751-0852)
- Sameek Roychowdhury (ORCID: https://orcid.org/0000-0002-8297-3038)
- Kai He
- John Hays
- Eric Min
- Paul Samuel
- Alexandra Diaz
Institutions
- The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
- The Ohio State University (US)
Publication Details
- Journal
- Gastroenterology Research
- Published
- 2024-12-01
- DOI
- https://doi.org/10.14740/gr1768
- Primary Topic
- Colorectal and Anal Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00